Det bliver ofte diskuteret om Skåne nu er - eller ikke er - eller burde være en del af Danmark!
Når det gælder den danske biomedicinske industri, så er Skåne for et par år siden smeltet sammen med Sjælland i det, som med henvisning til den amerikanske hightechs højborg Sillicon Valley, kaldes Medicon Valley.
Ved at slå virksomheder, der omfatter medicinalindustrier, biotekniske inkubatorer samt forskning på hospitaler og universiteter på Sjælland og i Skåne, sammen, har man skabt et af de stækest voksende bio-medicinske områder i Europa.
Her opstår der idéer og udvikles lægemidler og diagnostisk apparatur og -metode i verdensklasse.
Men i vor globaliserede verden kommer der sjældent meget godt ud af at lukke døren og være selvtilstrækkelig, og det er blandt andet derfor det danske videnskabsministerium har indgået en række bilaterale aftaler med lande som dansk videnskabelig forskning og industri kan have glæde af at udveksle ideer og erfaringer med.
Et af de lande der netop udmærker sig ved at have om muligt endnu mere fart på end Danmark når det gælder bio-teknologi og bio-medicin, er Israel.
Så for to år siden indgik Danmark og Israel en aftale om at samarbejde.
Derfor var Det danske Videnskabsministerium og flere danske biomedinske virksomheder i sidste uge i Tel Aviv til en stor international kongres for bl.a at præsentere Danmark. Interview med Jens Peter Vittrup fra Videnskabsministeriets innovationscenter og professor Eva Steiness, der er direktør i et af Danmarks yngste biomedicinske firmaer Neoloch.
24. juni 2009 kl. 17:10 på P1
· Samarbejde i den biomedicinske industri (11:18)
http://www.dr.dk/P1/orientering/indslag/2009/06/24/201021.htm
Tuesday, June 30, 2009
Thursday, June 25, 2009
Stellar Start-Ups: Multinational R&D centers as start-ups
They may be owned by large multinationals, but the research-and-development centers in Israel are more like start-ups, at least in spirit. They tackle thorny problems for their parent companies and invent new products and services that sometimes go on to change the direction of the multinationals, who find that the new product developed by their Israeli R&D unit has given them access to whole new markets and customers!
Like a start-up, a R&D center is expected to be innovative, flexible and generate new investments for its owners.
Without innovation, large companies end up stultifying; many of them rely on their R&D units to come up with the new innovations that will allow them to maintain their edge in the market. And many multinationals see Israel as their best bet when it comes to R&D, because of Israel's proven track record when it comes to innovation.
"We've found a huge pool of scientists, engineers and mathematicians full of innovative ideas. Israelis tend to think 'out of the box,' a trait highly valued at Google," says Brand.
I could go on and on - but you get the idea. Multinationals like Microsoft, Cisco and many others see their R&D centers as a great vehicle with which to tap into the "start-up spirit" of Israeli hi-tech professionals. In the words of Microsoft Israel CEO Danny Yamin, "Microsoft sees Israel as an excellent source of innovative workers, and we at MS Israel are proud of our contribution to Microsoft's worldwide development."
And Cisco's Israel director Bina Rezinovsky recently told the Post that "Israelis are imaginative, and they are familiar with technology, two traits that make the human resources of the country very valuable to Cisco."
They're just the traits that make start-ups so dynamic and innovative. Times may be tough, but they won't be forever. And when the economy does improve, Israeli hi-tech will be in a position to roar ahead, with the multinationals continuing to tap into their R&D "start-ups" for their next big thing!
Source: Jerusalem Post, David Shamah 03/05/2009
Like a start-up, a R&D center is expected to be innovative, flexible and generate new investments for its owners.
Without innovation, large companies end up stultifying; many of them rely on their R&D units to come up with the new innovations that will allow them to maintain their edge in the market. And many multinationals see Israel as their best bet when it comes to R&D, because of Israel's proven track record when it comes to innovation.
"We've found a huge pool of scientists, engineers and mathematicians full of innovative ideas. Israelis tend to think 'out of the box,' a trait highly valued at Google," says Brand.
I could go on and on - but you get the idea. Multinationals like Microsoft, Cisco and many others see their R&D centers as a great vehicle with which to tap into the "start-up spirit" of Israeli hi-tech professionals. In the words of Microsoft Israel CEO Danny Yamin, "Microsoft sees Israel as an excellent source of innovative workers, and we at MS Israel are proud of our contribution to Microsoft's worldwide development."
And Cisco's Israel director Bina Rezinovsky recently told the Post that "Israelis are imaginative, and they are familiar with technology, two traits that make the human resources of the country very valuable to Cisco."
They're just the traits that make start-ups so dynamic and innovative. Times may be tough, but they won't be forever. And when the economy does improve, Israeli hi-tech will be in a position to roar ahead, with the multinationals continuing to tap into their R&D "start-ups" for their next big thing!
Source: Jerusalem Post, David Shamah 03/05/2009
Thursday, June 18, 2009
Bravo, Economy!
Jun. 16, 2009
THE JERUSALEM POST
There was little hoopla locally yesterday, but there should have been: Israel's economy was upgraded by Morgan Stanley Capital Index (MSCI) from "emerging market" status and accorded recognition as a full-fledged "developed market."
This is no mean feat for a young country, a severely embattled one with few natural resources; one where virtually everything had to be started from scratch, often under the most adverse of conditions - including belligerence, boycotts and bad press.
MSCI is the world's leading provider of investment decision criteria for investment institutions. MSCI grading allows investors effective data-driven insights into various financial markets around the globe.
The MSCI did more than pat Israel on the back. In the Tel Aviv Stock Exchange, this is regarded as breaking the glass ceiling. Israel has been admitted to play in the exclusive and prestigious top league. This will surely make the competition tougher and require greater efforts and initiative, but it stands to attract investment opportunities incomparable to those that existed previously.
To put the reclassification into context, we need to realize that when it takes effect, in May 2010, Israel will rank 18th among the 24 developed market members, with a similar market weight to Denmark and Belgium and greater than Norway, Ireland, New Zealand, Portugal and Greece.
Further perspective is added by the fact that though South Korea's upgrading was mulled as well, it failed to make the grade this year and will be reevaluated in 2010, when Taiwan will also be up for possible promotion from emerging to developed market. Oil-rich United Arab Emirates, Qatar and Kuwait were being considered for advancement from their current "frontier market" status into the "emerging market" classification - which Israel has now outgrown. These Gulf States, however, it was decided, will remain where they are, their opulence notwithstanding.
WHY WAS Israel thus honored? Plainly, because we are doing well. With $134.5 billion in stock-market value, the TASE outdid most of its counterparts globally during the present crisis. The TA-25 Index of Tel Aviv shares surged 30 percent from January, beating 20 out of 23 developed markets tracked by MSCI.
Long-term, Israeli technology, pharmaceuticals and chemical companies are likely to be the reclassification's most outstanding beneficiaries. Yet in the short haul, trepidation surfaced. The very news that Israel is about to be sent to play in the big league contributed to significant TASE losses on Monday.
While the upgrade testifies to the strength of Israel's marketplace, there was safety in the big-frog-in-the-little-pond position. Now it is feared that some Israeli equities will become less attractive - a calculation which has indeed led to some sell-offs. Israeli securities might no longer be snapped up as thrift-store bargains, and Israel's overall share in the developed markets group will be considerably more modest than it was among the emerging (mostly Third World and East European) markets.
Funds that invest in emerging markets will probably be pulling out. Nonetheless, the cumulative effect of the negative aspects of the change will be far outweighed by the opening of new investment vistas.
The long-range outlook is far better than could have been expected just a few months back. Indeed, the Bank of Israel is expected to update its pessimistic predictions for 2009. There will still be negative growth, but not quite as bad as initially forecast.
Overall, the sense in the BOI is that the Israeli public isn't as gloomy as is common abroad, and that the global recession hasn't impacted Israel as drastically as it has other countries. Had Israel been in Europe, it would now rank fourth in growth on the continent.
THE acknowledgment of Israel as a developed market is more than just a merit badge. It carries with it real value in facilitating durable economic transactions with multinational partners. Israel's inclusion among the world's top markets is bound to alleviate investor anxieties, particularly during these times of acute risk-aversion.
We ought to congratulate ourselves on our tiny, beleaguered country's achievements, welcome the recognition these achievements are receiving from objective international assessors, and do our utmost to justify the confidence we inspire.
THE JERUSALEM POST
There was little hoopla locally yesterday, but there should have been: Israel's economy was upgraded by Morgan Stanley Capital Index (MSCI) from "emerging market" status and accorded recognition as a full-fledged "developed market."
This is no mean feat for a young country, a severely embattled one with few natural resources; one where virtually everything had to be started from scratch, often under the most adverse of conditions - including belligerence, boycotts and bad press.
MSCI is the world's leading provider of investment decision criteria for investment institutions. MSCI grading allows investors effective data-driven insights into various financial markets around the globe.
The MSCI did more than pat Israel on the back. In the Tel Aviv Stock Exchange, this is regarded as breaking the glass ceiling. Israel has been admitted to play in the exclusive and prestigious top league. This will surely make the competition tougher and require greater efforts and initiative, but it stands to attract investment opportunities incomparable to those that existed previously.
To put the reclassification into context, we need to realize that when it takes effect, in May 2010, Israel will rank 18th among the 24 developed market members, with a similar market weight to Denmark and Belgium and greater than Norway, Ireland, New Zealand, Portugal and Greece.
Further perspective is added by the fact that though South Korea's upgrading was mulled as well, it failed to make the grade this year and will be reevaluated in 2010, when Taiwan will also be up for possible promotion from emerging to developed market. Oil-rich United Arab Emirates, Qatar and Kuwait were being considered for advancement from their current "frontier market" status into the "emerging market" classification - which Israel has now outgrown. These Gulf States, however, it was decided, will remain where they are, their opulence notwithstanding.
WHY WAS Israel thus honored? Plainly, because we are doing well. With $134.5 billion in stock-market value, the TASE outdid most of its counterparts globally during the present crisis. The TA-25 Index of Tel Aviv shares surged 30 percent from January, beating 20 out of 23 developed markets tracked by MSCI.
Long-term, Israeli technology, pharmaceuticals and chemical companies are likely to be the reclassification's most outstanding beneficiaries. Yet in the short haul, trepidation surfaced. The very news that Israel is about to be sent to play in the big league contributed to significant TASE losses on Monday.
While the upgrade testifies to the strength of Israel's marketplace, there was safety in the big-frog-in-the-little-pond position. Now it is feared that some Israeli equities will become less attractive - a calculation which has indeed led to some sell-offs. Israeli securities might no longer be snapped up as thrift-store bargains, and Israel's overall share in the developed markets group will be considerably more modest than it was among the emerging (mostly Third World and East European) markets.
Funds that invest in emerging markets will probably be pulling out. Nonetheless, the cumulative effect of the negative aspects of the change will be far outweighed by the opening of new investment vistas.
The long-range outlook is far better than could have been expected just a few months back. Indeed, the Bank of Israel is expected to update its pessimistic predictions for 2009. There will still be negative growth, but not quite as bad as initially forecast.
Overall, the sense in the BOI is that the Israeli public isn't as gloomy as is common abroad, and that the global recession hasn't impacted Israel as drastically as it has other countries. Had Israel been in Europe, it would now rank fourth in growth on the continent.
THE acknowledgment of Israel as a developed market is more than just a merit badge. It carries with it real value in facilitating durable economic transactions with multinational partners. Israel's inclusion among the world's top markets is bound to alleviate investor anxieties, particularly during these times of acute risk-aversion.
We ought to congratulate ourselves on our tiny, beleaguered country's achievements, welcome the recognition these achievements are receiving from objective international assessors, and do our utmost to justify the confidence we inspire.
Thursday, June 11, 2009
DR Udland
DR Udland på DR2 har lavet nogle forskellige indslag om Israel, særligt interessant er indslaget om solceller.
Besøg venligst:
http://www.dr.dk/DR2/DR2+Udland/20090501134821.htm
Besøg venligst:
http://www.dr.dk/DR2/DR2+Udland/20090501134821.htm
Subscribe to:
Posts (Atom)